PEAK6 Investments’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,000
Closed -$236K 2279
2022
Q3
$236K Buy
+4,000
New +$236K ﹤0.01% 959